Serum drug concentrations predictive of pulmonary tuberculosis outcomes.
@article{Pasipanodya2013SerumDC, title={Serum drug concentrations predictive of pulmonary tuberculosis outcomes.}, author={Jotam G. Pasipanodya and H Mcilleron and Andr{\'e} Burger and Peter Wash and Peter Smith and Tawanda Gumbo}, journal={The Journal of infectious diseases}, year={2013}, volume={208 9}, pages={ 1464-73 } }
BACKGROUND
Based on a hollow-fiber system model of tuberculosis, we hypothesize that microbiologic failure and acquired drug resistance are primarily driven by low drug concentrations that result from pharmacokinetic variability.
METHODS
Clinical and pharmacokinetic data were prospectively collected from 142 tuberculosis patients in Western Cape, South Africa. Compartmental pharmacokinetic parameters of isoniazid, rifampin, and pyrazinamide were identified for each patient. Patients were then… CONTINUE READING
Figures, Tables, and Topics from this paper.
Citations
Publications citing this paper.
SHOWING 1-10 OF 152 CITATIONS, ESTIMATED 59% COVERAGE
Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment
VIEW 37 EXCERPTS
CITES METHODS, BACKGROUND & RESULTS
HIGHLY INFLUENCED
Understanding pharmacokinetics to improve tuberculosis treatment outcome.
VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED
Towards individualised treatment of tuberculosis
VIEW 10 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
VIEW 6 EXCERPTS
CITES BACKGROUND, RESULTS & METHODS
HIGHLY INFLUENCED
Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs.
VIEW 6 EXCERPTS
CITES BACKGROUND & METHODS
Novel treatment strategies for multidrug-resistant tuberculosis
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED
Re-defining Multidrug Resistant Tuberculosis Based on Clinical Response to 1 Combination Therapy 2
VIEW 8 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
Redefining multidrug-resistant tuberculosis based on clinical response to combination therapy.
VIEW 7 EXCERPTS
CITES BACKGROUND, RESULTS & METHODS
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
VIEW 4 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED
University of Groningen Clinical pharmacology and therapeutic drug monitoring of first-line anti-tuberculosis drugs
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED
FILTER CITATIONS BY YEAR
CITATION STATISTICS
9 Highly Influenced Citations
Averaged 22 Citations per year from 2017 through 2019
References
Publications referenced by this paper.
SHOWING 1-10 OF 46 REFERENCES